This data suggests a less sensitive response in obesity, probably due to a chronic stimulation leading to abnormalities of the SGLT2i-FGF-21 axis which should be considered in managing patients affected by genetic obesity. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.